Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) was the recipient of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,490,000 shares, a growth of 10.2% from the October 15th total of 2,260,000 shares. Based on an average daily volume of 940,200 shares, the days-to-cover ratio is currently 2.6 days. Approximately 1.9% of the company’s stock are short sold.
Henry Schein Stock Down 1.9 %
Henry Schein stock opened at $67.59 on Thursday. Henry Schein has a 1-year low of $60.01 and a 1-year high of $89.72. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.72 and a quick ratio of 0.91. The stock has a market cap of $8.83 billion, a PE ratio of 20.12, a P/E/G ratio of 1.87 and a beta of 0.87. The stock’s fifty day moving average is $70.39 and its two-hundred day moving average is $75.13.

Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings results on Monday, November 13th. The company reported $1.32 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.32. Henry Schein had a return on equity of 16.22% and a net margin of 3.51%. The company had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same period last year, the firm earned $1.15 earnings per share. Henry Schein’s quarterly revenue was up 3.1% on a year-over-year basis. On average, sell-side analysts expect that Henry Schein will post 5.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In
Several brokerages have recently issued reports on HSIC. Morgan Stanley decreased their price objective on Henry Schein from $69.00 to $65.00 and set an “underweight” rating for the company in a report on Tuesday. TheStreet cut Henry Schein from a “b-” rating to a “c+” rating in a report on Thursday, November 2nd. Barrington Research decreased their price objective on Henry Schein from $90.00 to $82.00 and set an “outperform” rating on the stock in a report on Tuesday. Bank of America decreased their price target on Henry Schein from $76.00 to $75.00 in a research note on Monday, August 7th. Finally, JPMorgan Chase & Co. upped their price target on Henry Schein from $80.00 to $83.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 9th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Henry Schein has an average rating of “Hold” and an average price target of $78.75.

Hedge Funds Weigh In On Henry Schein
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in Henry Schein by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 15,331,533 shares of the company’s stock valued at $1,336,756,000 after purchasing an additional 214,846 shares in the last quarter. Longview Partners Guernsey LTD grew its stake in shares of Henry Schein by 3.5% during the 1st quarter. Longview Partners Guernsey LTD now owns 7,263,670 shares of the company’s stock valued at $592,280,000 after buying an additional 248,659 shares during the period. Bank Julius Baer & Co. Ltd Zurich grew its stake in shares of Henry Schein by 67,055.8% during the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 6,737,741 shares of the company’s stock valued at $546,431,000 after buying an additional 6,727,708 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Henry Schein by 1.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock valued at $353,898,000 after buying an additional 53,506 shares during the period. Finally, Perpetual Ltd boosted its position in Henry Schein by 2.0% during the 2nd quarter. Perpetual Ltd now owns 4,347,251 shares of the company’s stock worth $352,562,000 after purchasing an additional 86,526 shares during the period. Hedge funds and other institutional investors own 93.31% of the company’s stock.

Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.